Confirming the Diagnosis: Genetics and Labs

Diagnosing CD27 deficiency is a complex process that often begins with a high degree of clinical suspicion. Because the condition is so rare, many patients are initially diagnosed with Common Variable Immunodeficiency (CVID) ^[1][2]. While both conditions involve low antibody levels and recurrent infections, the terminology and ongoing treatments may overlap, but confirming CD27 deficiency allows your medical team to provide much more targeted care and surveillance.

The Confusion with CVID

CVID is an “umbrella term” for various immune disorders that cause low levels of protective antibodies. Because people with CD27 deficiency often have hypogammaglobulinemia (low antibodies) and frequent sinus or lung infections, they frequently fit the broad criteria for CVID ^[1][3].

The critical “clue” that points away from a general CVID diagnosis and toward CD27 deficiency is how the patient reacts to the Epstein-Barr Virus (EBV). If a person with a CVID-like profile also develops severe “mono,” persistent high viral loads of EBV, or EBV-related complications like lymphoma or HLH, doctors should immediately investigate CD27 deficiency ^[4][5].

The Diagnostic Pathway

A molecular diagnosis generally depends on clinical assessment plus quantitative and functional immune evaluation, combined with appropriate genetic variant interpretation.

1. Flow Cytometry (Supportive Testing)

Flow cytometry is a lab test that uses lasers to count and examine individual cells in the blood. In this case, doctors use it to measure how much CD27 protein is on the surface of your T-cells and B-cells ^[4].

• A Helpful Clue: Most people with CD27 deficiency will have significantly reduced CD27 protein visible on their cells ^[4].
• The Limitation: Flow cytometry is supportive but not definitive. Expression varies with cell subset, activation, age, and assay. Healthy carriers (like parents of an affected child) often have lower-than-normal levels of CD27 on their cells but do not get sick ^[4]. Conversely, some patients with CVID may also show reduced CD27+ B-cells, and a normal or equivocal flow result does not necessarily exclude a functional defect ^[6].

2. Genetic Sequencing

To be certain, genetic testing of the TNFRSF7 gene is used. This test looks for specific errors in the gene that tells the body how to build CD27 ^[4][5]. Panel, exome, genome, or deletion/duplication methods may be used.

CD27 deficiency follows an autosomal recessive inheritance pattern. This means the sequencing must find biallelic pathogenic or likely pathogenic variants—errors in both copies of the gene (one from each parent) that fit the phenotype ^[4][7].

• Homozygous: The mutation is the same in both copies (common in families where parents are related).
• Compound Heterozygous: There are two different mutations, one in each copy.
• Targeted Variants: Finding a known pathogenic variant, such as S70P, provides strong evidence, as this specific mutation has been shown to severely impair CD27 expression ^[5].
• Variants of Uncertain Significance (VUS): A VUS does not establish the diagnosis. Functional or segregation studies, as well as genetic counseling and family testing, may be needed to reclassify a VUS.

Completeness Checklist for Your Lab Reports

If you are auditing your own or your child’s medical records, ensure that the following critical markers have been evaluated. These results together form the “clinical picture” of the condition. Do not self-diagnose from isolated laboratory values.

• Quantitative Immunoglobulins: Measurements of IgG, IgA, and IgM levels to assess antibody production ^[8][1].
• EBV Viral Load (PCR): A test that measures the amount of EBV DNA in the blood. Persistent levels are a monitoring tool, not an automatic diagnosis of lymphoma or HLH ^[5][4].
• Lymphocyte Subsets: A breakdown of T-cells, B-cells, and NK cells ^[8][9].
• Genetic Confirmation: A report confirming pathogenic or likely pathogenic mutations on both copies of the TNFRSF7 gene ^[4][7].

Once a specific genetic defect is confirmed, your medical team will provide much more targeted care tailored to your exact immune phenotype ^[10][11].